Background and Aims: To examine the effects of mindfulness-based interventions on gambling behavior and symptoms, urges, and financial outcomes. Method: Systematic review and meta-analytic procedures were employed to search, select, code, and analyze studies conducted between 1980 and 2014, assessing the effects of mindfulness-based interventions in the treatment of disordered gambling with adults. Results: Thirteen studies met criteria for this review and seven met criteria for meta-analysis. Effects were moderate to large for gambling behaviors/symptoms (g ¼ 0.68, 95% CI ¼ [0.39, 0.98], p < .01), gambling urges (g ¼ 0.69, 95% CI ¼ [0.18, 1.20], p < .01), and financial outcomes (g ¼ 0.75, 95% CI ¼ [0.24, 1.26], p < .01). Heterogeneity was low and nonsignificant. Conclusions: The findings provide support for mindfulness-based interventions in the treatment of disordered gambling. However, these results are necessarily tentative, limited by the number and quality of eligible studies, and differing conceptualizations of mindfulness.
The current study is a systematic replication and extension of work by Schweitzer & Sulzer-Azaroff (1988). The effects of delay fading alone and in combination with signals on choices between larger, delayed reinforcers and smaller, immediate reinforcers by four children with language deficits were examined. For one of the two children exposed to delay fading alone, larger reinforcers were selected at longer delays relative to the initial self-control assessment. For all four children, the delay-fading-plus-signal condition resulted in selection of larger reinforcers at considerably longer delays relative to the self-control assessment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.